Notice of Early Expiration of PA-19-077, “Accelerating Malaria Vaccine Discovery (R01 Clinical Trial Not Allowed)"
Notice Number:
NOT-AI-22-009

Key Dates

Release Date:

December 2, 2021

Related Announcements

PA-19-077 - Accelerating Malaria Vaccine Discovery (R01 Clinical Trial Not Allowed)

NOT-AI-22-014 - Notice of Special Interest (NOSI): Accelerating Malaria Vaccine Discovery

Issued by

National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

The purpose of this Notice is to inform the extramural community of the early expiration of PA-19-077 - Accelerating Malaria Vaccine Discovery (R01 Clinical Trial Not Allowed), effective immediately. The Key Dates section of the FOA has been modified to change the Expiration Date from January 8, 2022 to December 2, 2021.

Applicants are encouraged to consider applying to NOT-AI-22-014, “Notice of Special Interest (NOSI): Accelerating Malaria Vaccine Discovery”.

Inquiries

Please direct all inquiries to:

Annie Mo, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-627-3320
Email: moa@niaid.nih.gov